Related Experiment Video
Updated: Mar 30, 2026

07:10
Humanized NOD/SCID/IL2rγnull (hu-NSG) Mouse Model for HIV Replication and Latency Studies
Published on: January 7, 2019
16.5K
A Simple Mouse Model for the Study of Human Immunodeficiency Virus
Kang Chang Kim1, Byeong-Sun Choi2, Kyung-Chang Kim2
11 Department of Bio-industrial Technologies, College of Animal Bioscience and Technology, Konkuk University , Seoul, Korea.
AIDS Research and Human Retroviruses
|November 14, 2015
Summary
Researchers developed a simplified method to create humanized mouse models for HIV-1 studies. These hu-PBMC-NSG mice effectively model human immunodeficiency virus infection and treatment responses.
Area of Science:
- Immunology
- Virology
- Infectious Diseases
Background:
- Humanized mouse models are crucial for studying human viruses like HIV.
- Current methods for creating these models are complex and limit availability.
Purpose of the Study:
- To develop a simpler, more accessible method for constructing humanized mouse models for HIV-1 research.
- To evaluate the utility of these novel models in studying HIV-1 infection and therapeutic interventions.
Main Methods:
- NOD/SCID/IL2Rγ-null (NSG) mice were injected with human peripheral blood mononuclear cells (hu-PBMCs) without prior irradiation.
- The resulting hu-PBMC-NSG mice were infected with HIV-1 strains.
- Treatment efficacy of highly active antiretroviral therapy (HAART) and neutralizing antibodies was assessed.
Main Results:
- Human immune cells, including T cells, successfully engrafted in NSG mice.
- HIV-1 infected hu-PBMC-NSG mice exhibited CD4+ T cell depletion and high viral loads.
- HAART and antibody treatments effectively suppressed HIV-1 replication and prevented T cell loss.
- Human T cell numbers remained stable in the mice for at least 10 weeks.
Conclusions:
- The developed hu-PBMC-NSG mouse model offers a convenient and relevant platform for in vivo HIV-1 infection studies.
- This model facilitates research into HIV-1 pathogenesis and the evaluation of potential therapeutic drugs and vaccines.

